Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Methods to engineer a more effective T-cell attack on tumor cells are described that involve overproduction of IL-12 by the T cell in the tumor microenvironment.